Strategies for Resection Using Portal Vein Embolization: Hepatocellular Carcinoma and Hilar Cholangiocarcinoma

 

 Buy Article Permissions and Reprints

ABSTRACT

Preoperative portal vein embolization (PVE) is increasingly used to optimize the volume and function of the future liver remnant (FLR) and to reduce the risk for complications of major hepatectomy for hepatocellular carcinoma (HCC) or hilar cholangiocarcinoma (CCA). In patients with HCC who are candidates for extended hepatectomy and in patients with HCC and well-compensated cirrhosis who are being considered for major hepatectomy, FLR volumetry is routinely performed, and PVE is employed in selected cases to optimize the volume and function of the FLR prior to surgery. Similarly, in patients with hilar CCA who are candidates for extended hepatectomy, careful preoperative preparation using biliary drainage, FLR volumetry, and PVE optimizes the volume and function of the FLR prior to surgery. Appropriate use of PVE has led to improved postoperative outcomes after major hepatectomy for these diseases and oncological outcomes similar to those in patients who undergo resection without PVE. Specific indications for PVE are being clarified. FLR volumetry is necessary for proper selection of patients for PVE. Analysis of the degree of hypertrophy of the FLR after PVE (a dynamic test of liver regeneration) complements analysis of the pre-PVE FLR volume (a static test). Together, FLR degree of hypertrophy and FLR volume are the best predictors of outcome after major hepatectomy in an individual patient, regardless of the degree of underlying liver disease. This article synthesizes the literature on the approach to patients with HCC and CCA who are candidates for major hepatectomy. The rationale and indications for FLR volumetry and PVE and outcomes following PVE and major hepatectomy for HCC and CCA are discussed.

REFERENCES

• 1 Barbara L, Benzi G, Gaiani S et al.. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival.  Hepatology. 1992;  16(1) 132-137
  CrossrefPubMedGoogle Scholar
• 2 Ribero D, Abdalla E K, Thomas M B, Vauthey J N. Liver resection in the treatment of hepatocellular carcinoma.  Expert Rev Anticancer Ther. 2006;  6(4) 567-579
  CrossrefPubMedGoogle Scholar
• 3 El-Serag H B, Mason A C. Rising incidence of hepatocellular carcinoma in the United States.  N Engl J Med. 1999;  340(10) 745-750
  CrossrefPubMedGoogle Scholar
• 4 Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun M J. Cancer statistics, 2007.  CA Cancer J Clin. 2007;  57(1) 43-66
  CrossrefPubMedGoogle Scholar
• 5 Lau W Y, Ho S K, Yu S C, Lai E C, Liew C T, Leung T W. Salvage surgery following downstaging of unresectable hepatocellular carcinoma.  Ann Surg. 2004;  240(2) 299-305
  PubMedGoogle Scholar
• 6 Charoentum C, Thongprasert S, Chewaskulyong B, Munprakan S. Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma.  World J Gastroenterol. 2007;  13(20) 2852-2854
  PubMedGoogle Scholar
• 7 Lee J, Kim T Y, Lee M A et al.. Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas.  Cancer Chemother Pharmacol. 2008;  61(1) 47-52
  PubMedGoogle Scholar
• 8 Llovet J M, Real M I, Montana X et al.. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.  Lancet. 2002;  359(9319) 1734-1739
  CrossrefPubMedGoogle Scholar
• 9 Lo C M, Ngan H, Tso W K et al.. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.  Hepatology. 2002;  35(5) 1164-1171
  CrossrefPubMedGoogle Scholar
• 10 Macdonald O K, Crane C H. Palliative and postoperative radiotherapy in biliary tract cancer.  Surg Oncol Clin N Am. 2002;  11(4) 941-954
  CrossrefPubMedGoogle Scholar
• 11 Abdalla E K, Barnett C C, Doherty D, Curley S A, Vauthey J N. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization.  Arch Surg. 2002;  137(6) 675-680 discussion 680-671
  CrossrefPubMedGoogle Scholar
• 12 Vauthey J N, Chaoui A, Do K A et al.. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations.  Surgery. 2000;  127(5) 512-519
  CrossrefPubMedGoogle Scholar
• 13 Shirabe K, Shimada M, Gion T et al.. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume.  J Am Coll Surg. 1999;  188(3) 304-309
  CrossrefPubMedGoogle Scholar
• 14 Abdalla E K, Hicks M E, Vauthey J N. Portal vein embolization: rationale, technique and future prospects.  Br J Surg. 2001;  88(2) 165-175
  CrossrefPubMedGoogle Scholar
• 15 Kubota K, Makuuchi M, Kusaka K et al.. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors.  Hepatology. 1997;  26(5) 1176-1181
  PubMedGoogle Scholar
• 16 Ribero D, Chun Y S, Vauthey J-N. Standardized liver volumetry for portal vein embolization.  Semin Intervent Radiol. 2008;  25 104-109
  Article in Thieme ConnectPubMedGoogle Scholar
• 17 Vauthey J N, Pawlik T M, Abdalla E K et al.. Is extended hepatectomy for hepatobiliary malignancy justified?.  Ann Surg. 2004;  239(5) 722-730 discussion 730-722
  CrossrefPubMedGoogle Scholar
• 18 Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma.  World J Surg. 1986;  10(5) 803-808
  Google Scholar
• 19 Makuuchi M, Thai B L, Takayasu K et al.. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report.  Surgery. 1990;  107(5) 521-527
  Google Scholar
• 20 Uesaka K, Nimura Y, Nagino M. Changes in hepatic lobar function after right portal vein embolization: an appraisal by biliary indocyanine green excretion.  Ann Surg. 1996;  223(1) 77-83
  Google Scholar
• 21 Hirai I, Kimura W, Fuse A, Suto K, Urayama M. Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy.  Surgery. 2003;  133(5) 495-506
  CrossrefPubMedGoogle Scholar
• 22 Madoff D C, Hicks M E, Vauthey J N et al.. Transhepatic portal vein embolization: anatomy, indications, and technical considerations.  Radiographics. 2002;  22(5) 1063-1076
  PubMedGoogle Scholar
• 23 Nagino M, Nimura Y, Kamiya J et al.. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization.  Hepatology. 1995;  21(2) 434-439
  CrossrefPubMedGoogle Scholar
• 24 Nagino M, Kanai M, Morioka A et al.. Portal and arterial embolization before extensive liver resection in patients with markedly poor functional reserve.  J Vasc Interv Radiol. 2000;  11(8) 1063-1068
  CrossrefPubMedGoogle Scholar
• 25 Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.  Ann Surg. 2003;  238(5) 720-727
  CrossrefPubMedGoogle Scholar
• 26 Madoff D C, Abdalla E K, Vauthey J N. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care.  J Vasc Interv Radiol. 2005;  16(6) 779-790
  PubMedGoogle Scholar
• 27 Ribero D, Abdalla E K, Madoff D C, Donadon M, Loyer E M, Vauthey J N. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome.  Br J Surg. 2007;  94(11) 1386-1394
  CrossrefPubMedGoogle Scholar
• 28 Azoulay D, Castaing D, Krissat J et al.. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver.  Ann Surg. 2000;  232(5) 665-672
  CrossrefPubMedGoogle Scholar
• 29 Farges O, Belghiti J, Kianmanesh R et al.. Portal vein embolization before right hepatectomy: prospective clinical trial.  Ann Surg. 2003;  237(2) 208-217
  Google Scholar
• 30 Denys A, Lacombe C, Schneider F et al.. Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis.  J Vasc Interv Radiol. 2005;  16(12) 1667-1674
  PubMedGoogle Scholar
• 31 Goto Y, Nagino M, Nimura Y. Doppler estimation of portal blood flow after percutaneous transhepatic portal vein embolization.  Ann Surg. 1998;  228(2) 209-213
  CrossrefPubMedGoogle Scholar
• 32 Shimada R, Imamura H, Nakayama A, Miyagawa S, Kawasaki S. Changes in blood flow and function of the liver after right portal vein embolization.  Arch Surg. 2002;  137(12) 1384-1388
  PubMedGoogle Scholar
• 33 Makuuchi M, Kosuge T, Lygidakis N J. New possibilities for major liver surgery in patients with Klatskin tumors or primary hepatocellular carcinoma: an old problem revisited.  Hepatogastroenterology. 1991;  38(4) 329-336
  PubMedGoogle Scholar
• 34 Yamanaka N, Okamoto E, Kawamura E et al.. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function.  Hepatology. 1993;  18(1) 79-85
  PubMedGoogle Scholar
• 35 Nagino M, Ando M, Kamiya J, Uesaka K, Sano T, Nimura Y. Liver regeneration after major hepatectomy for biliary cancer.  Br J Surg. 2001;  88(8) 1084-1091
  CrossrefPubMedGoogle Scholar
• 36 Yamakado K, Takeda K, Matsumura K et al.. Regeneration of the un-embolized liver parenchyma following portal vein embolization.  J Hepatol. 1997;  27(5) 871-880
  CrossrefPubMedGoogle Scholar
• 37 Nagino M, Kamiya J, Kanai M et al.. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility.  Surgery. 2000;  127(2) 155-160
  CrossrefPubMedGoogle Scholar
• 38 Madoff D C, Abdalla E K, Gupta S et al.. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils.  J Vasc Interv Radiol. 2005;  16(2) 215-225
  CrossrefPubMedGoogle Scholar
• 39 Wakabayashi H, Ishimura K, Okano K et al.. Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma.  Surgery. 2002;  131(1) 26-33
  Google Scholar
• 40 Abdalla E K, Denys A, Chevalier P, Nemr R A, Vauthey J N. Total and segmental liver volume variations: implications for liver surgery.  Surgery. 2004;  135(4) 404-410
  CrossrefPubMedGoogle Scholar
• 41 Urata K, Kawasaki S, Matsunami H et al.. Calculation of child and adult standard liver volume for liver transplantation.  Hepatology. 1995;  21(5) 1317-1321
  CrossrefPubMedGoogle Scholar
• 42 Johnson T N, Tucker G T, Tanner M S, Rostami-Hodjegan A. Changes in liver volume from birth to adulthood: a meta-analysis.  Liver Transpl. 2005;  11(12) 1481-1493
  CrossrefPubMedGoogle Scholar
• 43 Imamura H, Seyama Y, Kokudo N et al.. One thousand fifty-six hepatectomies without mortality in 8 years.  Arch Surg. 2003;  138(11) 1198-1206 discussion 1206
  CrossrefPubMedGoogle Scholar
• 44 Takayama T, Makuuchi M. Preoperative portal vein embolization: is it useful?.  J Hepatobiliary Pancreat Surg. 2004;  11(1) 17-20
  CrossrefPubMedGoogle Scholar
• 45 Tanaka H, Hirohashi K, Kubo S, Shuto T, Higaki I, Kinoshita H. Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function.  Br J Surg. 2000;  87(7) 879-882
  CrossrefPubMedGoogle Scholar
• 46 Lee K C, Kinoshita H, Hirohashi K, Kubo S, Iwasa R. Extension of surgical indications for hepatocellular carcinoma by portal vein embolization.  World J Surg. 1993;  17(1) 109-115
  Google Scholar
• 47 Kodama Y, Shimizu T, Endo H, Miyamoto N, Miyasaka K. Complications of percutaneous transhepatic portal vein embolization.  J Vasc Interv Radiol. 2002;  13(12) 1233-1237
  CrossrefPubMedGoogle Scholar
• 48 Di Stefano D R, de Baere T, Denys A et al.. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients.  Radiology. 2005;  234(2) 625-630
  CrossrefPubMedGoogle Scholar
• 49 Hemming A W, Reed A I, Howard R J et al.. Preoperative portal vein embolization for extended hepatectomy.  Ann Surg. 2003;  237(5) 686-691 discussion 691-683
  CrossrefPubMedGoogle Scholar
• 50 Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma.  Br J Surg. 2006;  93(9) 1091-1098
  CrossrefPubMedGoogle Scholar
• 51 Aoki T, Imamura H, Hasegawa K et al.. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma.  Arch Surg. 2004;  139(7) 766-774
  PubMedGoogle Scholar
• 52 Makuuchi M. Remodeling the surgical approach to hepatocellular carcinoma.  Hepatogastroenterology. 2002;  49(43) 36-40
  PubMedGoogle Scholar
• 53 Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores: where are we and where should we go?.  J Hepatol. 2004;  41(2) 344-350
  CrossrefPubMedGoogle Scholar
• 54 Sugawara Y, Yamamoto J, Higashi H et al.. Preoperative portal embolization in patients with hepatocellular carcinoma.  World J Surg. 2002;  26(1) 105-110
  CrossrefPubMedGoogle Scholar
• 55 Imamura H, Shimada R, Kubota M et al.. Preoperative portal vein embolization: an audit of 84 patients.  Hepatology. 1999;  29(4) 1099-1105
  CrossrefPubMedGoogle Scholar
• 56 Wakabayashi H, Ishimura K, Okano K et al.. Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma?.  Cancer. 2001;  92(9) 2384-2390
  CrossrefPubMedGoogle Scholar
• 57 Liu C L, Fan S T, Cheung S T, Lo C M, Ng I O, Wong J. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study.  Ann Surg. 2006;  244(2) 194-203
  CrossrefPubMedGoogle Scholar
• 58 Ogata S, Belghiti J, Varma D et al.. Two hundred liver hanging maneuvers for major hepatectomy: a single-center experience.  Ann Surg. 2007;  245(1) 31-35
  CrossrefPubMedGoogle Scholar
• 59 Donadon M, Abdalla E K, Vauthey J N. Liver hanging maneuver for large or recurrent right upper quadrant tumors.  J Am Coll Surg. 2007;  204(2) 329-333
  CrossrefPubMedGoogle Scholar
• 60 Belghiti J, Guevara O A, Noun R, Saldinger P F, Kianmanesh R. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization.  J Am Coll Surg. 2001;  193(1) 109-111
  CrossrefPubMedGoogle Scholar
• 61 Kim S H, Park S J, Lee S A et al.. Various liver resections using hanging maneuver by three glisson's pedicles and three hepatic veins.  Ann Surg. 2007;  245(2) 201-205
  CrossrefPubMedGoogle Scholar
• 62 Aloia T A, Charnsangavej C, Faria S et al.. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma.  Am J Surg. 2007;  193(6) 702-706
  CrossrefPubMedGoogle Scholar
• 63 Kawasaki S, Makuuchi M, Miyagawa S, Kakazu T. Radical operation after portal embolization for tumor of hilar bile duct.  J Am Coll Surg. 1994;  178(5) 480-486
  PubMedGoogle Scholar
• 64 Kanai M, Nimura Y, Kamiya J et al.. Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus.  Surgery. 1996;  119(5) 498-504
  CrossrefPubMedGoogle Scholar
• 65 Miyagawa S, Makuuchi M, Kawasaki S. Outcome of extended right hepatectomy after biliary drainage in hilar bile duct cancer.  Arch Surg. 1995;  130(7) 759-763
  PubMedGoogle Scholar
• 66 Ishizawa T, Hasegawa K, Sano K, Imamura H, Kokudo N, Makuuchi M. Selective versus total biliary drainage for obstructive jaundice caused by a hepatobiliary malignancy.  Am J Surg. 2007;  193(2) 149-154
  CrossrefPubMedGoogle Scholar
• 67 Chang W H, Kortan P, Haber G B. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage.  Gastrointest Endosc. 1998;  47(5) 354-362
  PubMedGoogle Scholar
• 68 Abdalla E K, Vauthey J N, Couinaud C. The caudate lobe of the liver: implications of embryology and anatomy for surgery.  Surg Oncol Clin N Am. 2002;  11(4) 835-848
  CrossrefPubMedGoogle Scholar
• 69 Leelaudomlipi S, Sugawara Y, Kaneko J, Matsui Y, Ohkubo T, Makuuchi M. Volumetric analysis of liver segments in 155 living donors.  Liver Transpl. 2002;  8(7) 612-614
  CrossrefPubMedGoogle Scholar
• 70 Jarnagin W R, Conlon K, Bodniewicz J et al.. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases.  Cancer. 2001;  91(6) 1121-1128
  CrossrefPubMedGoogle Scholar
• 71 Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.  Ann Surg. 2006;  243(3) 364-372
  CrossrefPubMedGoogle Scholar
• 72 Neuhaus P, Jonas S, Bechstein W O et al.. Extended resections for hilar cholangiocarcinoma.  Ann Surg. 1999;  230(6) 808-818 discussion 819
  CrossrefPubMedGoogle Scholar
• 73 Neuhaus P, Jonas S, Settmacher U et al.. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality.  Langenbecks Arch Surg. 2003;  388(3) 194-200
  CrossrefPubMedGoogle Scholar
• 74 Tsao J I, Nimura Y, Kamiya J et al.. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience.  Ann Surg. 2000;  232(2) 166-174
  CrossrefPubMedGoogle Scholar
• 75 Nimura Y, Kamiya J, Kondo S et al.. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience.  J Hepatobiliary Pancreat Surg. 2000;  7(2) 155-162
  CrossrefPubMedGoogle Scholar
• 76 Saldinger P F, Blumgart L H. Resection of hilar cholangiocarcinoma: a European and United States experience.  J Hepatobiliary Pancreat Surg. 2000;  7(2) 111-114
  CrossrefPubMedGoogle Scholar
• 77 Tabata M, Kawarada Y, Yokoi H, Higashiguchi T, Isaji S. Surgical treatment for hilar cholangiocarcinoma.  J Hepatobiliary Pancreat Surg. 2000;  7(2) 148-154
  CrossrefPubMedGoogle Scholar
• 78 Liu C L, Fan S T, Lo C M, Tso W K, Lam C M, Wong J. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma.  Br J Surg. 2006;  93(12) 1488-1494
  CrossrefPubMedGoogle Scholar
• 79 Seyama Y, Kubota K, Sano K et al.. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate.  Ann Surg. 2003;  238(1) 73-83
  CrossrefPubMedGoogle Scholar
• 80 Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization.  Ann Surg. 2003;  238(1) 84-92
  CrossrefPubMedGoogle Scholar

Eddie K AbdallaM.D. 

Assistant Professor, Hepatobiliary Surgery and Surgical Oncology, Department of Surgical Oncology

Unit 444, The University of Texas M. D. Anderson Cancer Center, 1400 Holcombe Boulevard, Suite 12.2016, Houston, TX 77030

Email: eabdalla@mdanderson.org